Benefit-18
Commercial- Indications
- Prematurity
Company intelligence / Profile preview
Medolac developed the first commercially sterile human donor milk product. Their products are currently used by hospital NICUs nationwide. The company applies proprietary processing to preserve immune components while ensuring safety and room-temperature stability. No clinical trial data typical of drug development; efficacy relates to nutritional/clinical outcomes in neonatology.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medolac Laboratories.